Latest Articles

Publication Date
Biokin Pharmaceutical Obtains Approval for Cervical, Endometrial Cancer Clinical Trial - marketscreener.com

Biokin Pharmaceutical Obtains Approval for Cervical, Endometrial Cancer Clinical Trial marketscreener.com

Published: April 28, 2025, 9:23 a.m.
The emergence of BTK inhibitors in multiple sclerosis treatment: Companies close in on approval - Labiotech.eu

The emergence of BTK inhibitors in multiple sclerosis treatment: Companies close in on approval Labiotech.eu

Published: April 23, 2025, 1:01 p.m.
Hailey Bieber Reveals Her 'Shocking' Health Condition Has RETURNED Amid Husband Justin's Latest Worrying Behavior During Drug-Fueled Coachella Appearance - RadarOnline

Hailey Bieber Reveals Her 'Shocking' Health Condition Has RETURNED Amid Husband Justin's Latest Worrying Behavior During Drug-Fueled Coachella Appearance RadarOnline

Published: April 22, 2025, 3:23 p.m.
Hailey Bieber Reveals Her 'Shocking' Health Condition Has RETURNED Amid Husband Justin's Latest Worrying Behavior During Drug-Fueled Coachella Appearance - radaronline.com

Hailey Bieber Reveals Her 'Shocking' Health Condition Has RETURNED Amid Husband Justin's Latest Worrying Behavior During Drug-Fueled Coachella Appearance radaronline.com

Published: April 22, 2025, 3:23 p.m.
‘the endometriosis pay gap costs women £130 every month – i should know’ - Readly | All magazines - one magazine app subscription

‘the endometriosis pay gap costs women £130 every month – i should know’ Readly | All magazines - one magazine app subscription

Published: April 22, 2025, 3:35 a.m.
4 doctor-approved tricks to tackle endometriosis pain without missing a beat at work - Hindustan Times

4 doctor-approved tricks to tackle endometriosis pain without missing a beat at work Hindustan Times

Published: April 21, 2025, 1:38 p.m.
Pearsanta to begin study of endometriosis test with IRB approval - MSN

Pearsanta to begin study of endometriosis test with IRB approval MSN

Published: April 19, 2025, 1:06 a.m.
Dostarlimab/Chemo Earns Expanded Canadian Approval in Primary Advanced, First Recurrent Endometrial Cancer - OncLive

Dostarlimab/Chemo Earns Expanded Canadian Approval in Primary Advanced, First Recurrent Endometrial Cancer OncLive

Published: April 18, 2025, 3:54 p.m.
‘Incredibly disappointing’: Period pain education program scrapped - The Mercury

‘Incredibly disappointing’: Period pain education program scrapped The Mercury

Published: April 18, 2025, 7:05 a.m.
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - BioSpace

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 18, 2025, 5:25 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!